Abstract
In order to investigate the feasibility of the assessment of renal function with99mTc-MDP, we compared renographical images, renogram patterns and the glomerular filtration rate (GFR) obtained by means of a modified Gates’ method and 200 MBq of99mTc-MDP with those obtained by means of99mTc-DTPA. Because 19 of 20 patients had malignant tumors in the genitourinary tract, there was no difference between the two tracers in identifying a parenchymal defect corresponding to renal cancer. Of eight patients with hydronephrosis, four had a defect or decreased uptake with a dilated pelvis, whereas the other four had marked radioisotope retention in the renal pelvis or the whole kidney on serial images. There was also no difference between the two tracers in identifying hydronephrosis. Of 38 paired renograms 35 showed the same renogram patterns with both tracers. Of three patients with different renogram patterns, two had hydronephrosis. In 20 patients including three patients with bone metastasis, total GFR and split GFR obtained with both tracers correlated with a correlation coefficient of r=0.920 (p<0.001) and r=0.944 (p<0.001), respectively. Excluding bone metastasis from the analysis, a linear-regression analysis showed excellent agreement between the two measurements with a correlation coefficient of r=0.960 (p<0.001) and r=0.963 (p<0.001), respectively. The linear regression equations were Y=1.009X −0.111 and Y=1.034X−0.714, respectively. In conclusion,99mTc-MDP can be used as a supplement to evaluate renal function incidental to the survey of bone metastases in patients with malignant tumor.
Similar content being viewed by others
References
Gates GF. Split renal function testing using99mTc-DTPA: a rapid technique for determining differential glomerular filtration.Clin Nucl Med 1983; 8: 400–407.
Taylor A. Radionuclide renography: a personal approach.Semin Nucl Med 1999; 29: 102–127.
Glass EC, DeNardo GL, Hines HH. Immediate renal imaging and renography with99mTc methylene diphosphonate to assess renal blood flow, excretory function, and anatomy.Radiology 1980; 135: 187–190.
Adams KJ, Shuler SE, Witherspoon LR, Neely HR. A retrospective analysis of renal abnormalities detected on bone scans.Clin Nucl Med 1980; 5: 1–7.
Koizumi K, Tonami N, Hisada K. Diffusely increased Tc-99m-MDP uptake in both kidneys.Clin Nucl Med 1981; 6: 362–365.
Chayes ZW, Strashun AM. Improved renal screening on bone scans.Clin Nucl Med 1980; 5: 94–97.
Jacobson AF. Diffuse renal retention on bone scintigraphy in localized clear-cell renal epithelial neoplasm.J Nucl Med 1995; 36: 817–819.
haden HT, Katz PG, Konerding KF. Detection of obstructive uropathy by bone scintigraphy.J Nucl Med 1988; 29: 1781–1785.
Itoh K, Tsukamoto E, Nagao K, Nakada K, Kanegae K, Furudate M. Captopril renography with Tc-99m DTPA in patients with suspected renovascular hypertension prospective and retrospective evaluation.Clin Nucl Med 1993; 18: 463–471.
Bilchik TR, Spencer RP. Bladder variants noted on bone and renal imaging.Clin Nucl Med 1993; 18: 60–67.
Zuckier LS, Weissmann HS, Kaplun L, Schlossberg I, Gade MF, Freeman LM. Significance of skeletal uptake detected on radionuclide renal perfusion studies.Clin Nucl Med 1987; 12: 448–452.
Vieras F, Achong DM, Tulchinsky M, Smith JJ. Quantitation of differential renal function with Tc-99m MDP.Clin Nucl Med 1991; 16: 649–651.
Yamashita M, Miyazaki T, Imahori Y, Ohmori Y, Oka T, Murakami K. Renogram study using99mTc-methylenediphosphonate.Radioisotopes 1985; 34: 382–385.
Russell CD, Bischoff PG, Konzen F, Rowell KL, Yester MV, Lloyd LK, et al. Measurement of glomerular filtration rate using99mTc-DTPA and the gamma camera: a comparison of methods.Eur J Nucl Med 1985; 10: 519–521.
Awdeh M, Kouris K, Hassan IM, Abdel Dayem HM. Factors affecting the Gates’ measurement of glomerular filtration rate.Am J Physiol Imag 1990; 5: 36–41.
Siddiqui AR. Increased uptake of technetium-99m-labeled bone imaging agents in kidneys.Semin Nucl Med 1982; 12: 101–102.
Lutrin CL, McDougall IR, Goris ML. Intense concentration of Tc-99m-pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease.Radiology 1978; 128: 165–167.
Arbona GL, Antonmattei S, Tetalman MR, Scheu JD. Tc-99m-diphosphonate distribution in a patient with hypercalcemia and metastatic calcifications.Clin Nucl Med 1980; 5: 422.
Sheth KJ, Sty JR, Johnson F, Tisdale P. Myoglobinuria with acute renal failure and hot kidneys seen on bone imaging.Clin Nucl Med 1984; 9: 498–501.
Lantieri RL, Lin MS, Martin W, Goodwin DA. Increased renal accumulation of Tc-99m-MDP in renal artery stenosis.Clin Nucl Med 1980; 5: 305–309.
Lamki LM, Wyatt JK. Renal vein thrombosis as a cause of excess renal accumulation of bone seeking agents.Clin Nucl Med 1983; 8: 267–268.
Titelbaum DS, Fowble BF, Powe JF, Martinez FJ. Renal uptake of technetium-99m methylene diphosphonate following therapeutic radiation for vertebral metastases.J Nucl Med 1989; 30: 1113–1116.
Choy D, Murray PC, Hoschl R. The effect of iron on the biodistribution of bone scanning agents in humans.Radiology 1981; 140: 197–202.
Watanabe N, Shimizu M, Kageyama M, Kamei T, Seto H, Kakishita M. Diffuse increased renal uptake on bone scintigraphy in acute renal tubular necrosis.Clin Nucl Med 1993; 19: 19–21.
Challa S, Miller JF. Extraskeletal uptake of technetium-99m-MDP in sites of heparin administration.J Nucl Med 1998; 39: 893–895.
Bernard MS, Hayward M, Hayward C, Mundy L. Evaluation of intense renal parenchymal activity (“hot kidneys”) on bone scintigraphy.Clin Nucl Med 1990; 15: 254–256.
Taylor A, Corrigan P, Galt J, Garcia EV, Forks R, Jones M, et al. Measuring Tc-99m MAG3 clearance with an improved camera based method.J Nucl Med 1995; 36: 1689–1695.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takayama, T., Kinuya, S., Kobashi, K. et al. Clinical approach to renal study incidental to99mTc-MDP bone scintigraphy. Ann Nucl Med 15, 237–245 (2001). https://doi.org/10.1007/BF02987838
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02987838